Upcoming Diabetes & Endocrinology Conferences
Diabetes & Endocrinology Conferences 2019
3rd International Conference on Endocrinology and Metabolic SyndromeAmsterdam, Netherlands
Global Experts Meeting on Diabetes, Hypertension & Metabolic SyndromeMelbourne, Australia
24th International Conference on Herbal and Alternative Therapies For DiabetesSingapore City, Singapore
2nd International Conference on Clinical Diabetes, Diabetic Medication &TreatmentMontreal, Canada
29th International Congress on Prevention Of Diabetes and ComplicationsBerlin, Germany
2nd International Conference on Diabetes and Diabetic Nursing CareMontreal, Canada
12th International Conference on Endocrinology,Diabetes and MetabolismOsaka, Japan
Conferences By Continents
USA & Americas
Asia-Pacific & Middle East
Conferences By Subject
Target Audience for Diabetes and Endocrinology Conferences
Medical doctors, patients and health care providers consider the prevention of Diabetes and Endocrinology diseases as an essential tool to improve the general health status of the population. The proportions of people suffering from the disease are expected to increase in future according a recent statistical survey.
- Diabetes students, Scientists
- Diabetes Researchers
- Diabetes and Endocrinology Faculty
- Medical Colleges
- Diabetes and Endocrine Associations and Societies
- Endocrine surgeons
- Diabetes Specialists
Benefits of Attending CME Conferences
Earning continuing medical education credits is a requirement in many health professionals to be board-certified and maintain their license. Those who must earn CME credits can do online or at live conferences. While online programs offer convenience and allow doctors to complete them on their own schedule. Continuing medical education (CME) helps those in the medical field maintain competence and learn about new and developing areas of their field. These activities may take place as live events, written publications, online programs, audio, video, or other electronic media. Content for these programs is developed, reviewed, and delivered by faculty who are experts in their individual clinical areas. Similar to the process used in academic journals, any potentially conflicting financial relationships for faculty members must be both disclosed and resolved in a meaningful way. However, critics complain that drug and device manufacturers often use their financial sponsorship to bias CMEs towards marketing their own products.
Benefits of Attending CPD/CE Conferences
The benefits of CPD aren’t felt just when you’re going for promotion or upgrading to Chartered membership. Many employers now value ‘learning agility’ as a core competency.
- Build confidence and credibility; you can see your progression by tracking your learning.
- Earn more by showcasing your achievements. A handy tool for appraisals.
- Achieve your career goals by focussing on your training and development.
- Cope positively with change by constantly updating your skill set.
- Be more productive and efficient by reflecting on your learning and highlighting gaps in your knowledge and experience.
Continuing education is an all-encompassing term within a broad list of post-secondary learning activities and programs. Recognized forms of post-secondary learning activities within the domain include: degree credit courses by non-traditional students, non-degree career training, workforce training, formal personal enrichment courses (both on-campus and online) self-directed learning (such as through Internet interest groups, clubs or personal research activities) and experiential learning as applied to problem solving.
Market Value of Diabetes and Endocrinology
USA: Diabetes and Endocrine diseases has been growing at an exponential rate and World Health Organization (WHO) estimates that the population is likely to reach 412 million in 2035. The United States is expected to have an increase of 102 per cent in the diabetic epidemic in 2035 when compared to 2000.
Europe: The number of people living with diabetes and Endocrinology diseases in Europe is expected to increase from 60 million in 2014 to 72.9 million by 2040, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 15 adults is affected and this number is set to rise as the population ages.
Asia Pacific: The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.569 Billion in 2016 and is projected to reach USD 4.317 billion by 2025, at a CAGR of 8.58% during the forecast period from 2016 to 2025.